Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NYXH
#3857
Nyxoah SA Ordinary Shares
3.2
7
USD
+10.47%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+10.47%
Mudança mensal
+4.14%
Mudança em 6 meses
-46.39%
Mudança anual
-45.59%
Fechamento anterior
2.9
6
Abrir
3.2
7
Bid
Ask
Mínimo
3.2
7
High
3.2
7
Volume
1
Mercados
Ações
Cuidados de saúde
NYXH
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
25.77 M
25.85 M
28.67 M
37.43 M
43.03 M
134.97 M
Valuation ratios
Enterprise value
592.76 M
136.73 M
135.48 M
299.42 M
197.92 M
769.55 M
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
—
—
—
—
—
Return on equity %
—
—
—
—
—
—
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
—
—
—
—
—
—
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
Notícias
Stifel reduz preço-alvo da Nyxoah para US$ 8 após revisão
Nyxoah SA (NYXH) Q4 2025 Earnings Call Transcript
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
Nyxoah na conferência da Oppenheimer: foco estratégico no lançamento nos EUA
Nyxoah at Oppenheimer Conference: Strategic U.S. Launch Focus
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
Veeva Systems (VEEV) Q4 Earnings and Revenues Surpass Estimates
Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Stifel reitera recomendação de compra para ações da Nyxoah, mantém preço-alvo de US$ 12
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target
Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System
Inspire Medical Systems stock soars after Medicare reimbursement boost